000			01934 a2200493 4500
005			20250517044531.0
264		0	_c20161213
008			201612s 0 0 eng d
022			_a2092-9382
024	7		_a10.3341/kjo.2015.29.4.226 _2doi
040			_aNLM _beng _cNLM
100	1		_aMoon, Da Ru Chi
245	0	0	_aAflibercept Treatment for Neovascular Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy Refractory to Anti-vascular Endothelial Growth Factor. _h[electronic resource]
260			_bKorean journal of ophthalmology : KJO _c08 2015
300			_a226-32 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAngiogenesis Inhibitors _xadministration & dosage
650	0	4	_aBevacizumab _xadministration & dosage
650	0	4	_aChoroid _xblood supply
650	0	4	_aChoroid Diseases _xcomplications
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aHumans
650	0	4	_aIntravitreal Injections
650	0	4	_aMale
650	0	4	_aRanibizumab _xadministration & dosage
650	0	4	_aReceptors, Vascular Endothelial Growth Factor _xadministration & dosage
650	0	4	_aRecombinant Fusion Proteins _xadministration & dosage
650	0	4	_aRetinal Neovascularization _xcomplications
650	0	4	_aRetrospective Studies
650	0	4	_aTomography, Optical Coherence
650	0	4	_aTreatment Outcome
650	0	4	_aVascular Endothelial Growth Factor A _xantagonists & inhibitors
650	0	4	_aVisual Acuity
650	0	4	_aWet Macular Degeneration _xdiagnosis
700	1		_aLee, Dong Kyu
700	1		_aKim, Soon Hyun
700	1		_aYou, Yong Sung
700	1		_aKwon, Oh Woong
773	0		_tKorean journal of ophthalmology : KJO _gvol. 29 _gno. 4 _gp. 226-32
856	4	0	_uhttps://doi.org/10.3341/kjo.2015.29.4.226 _zAvailable from publisher's website
999			_c25137492 _d25137492